Don't get defensive. You are not getting what I am saying. I like the their results so far. My point is that insider buying means nothing ESPECIALLY in the biotech world. These studies are blinded and no one knows how it's going. We also don't know about side-effects, statististical signifcance. How many times have you seen spectaculr Phase II's only to be killed in phase III. Despite this, their great phase II is why I am long. By the way.. Insiders sell for many reasons and it's not always bad. Notoriously they sell waaaaay too early.